Ads
related to: moderna vaccine
Search results
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 19 hours agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 2 days agoDepartment of Health and Human Services, could total several tens of millions of dollars and include...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 1 day agoAs concerns grow about the H5 bird flu, Moderna and fellow Covid jab maker Pfizer say they're ready...
Moderna's RSV vaccine for older adults approved
Axios· 18 hours agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 22 hours agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 22 hours agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 23 hours agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 15 hours agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 18 hours agoThis will be the only RSV vaccine available in single-dose prefilled syringes and will be sold under...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 1 day agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.